Molecular Diagnostics: Technologies and Global Markets

Report Code: BIO063B

Publish Date: Mar 2013

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

In 2012, the global DNA diagnostics market was valued at $17.3 billion. The total market is projected to reach $20.1 billion in 2013 and nearly $36.5 billion by 2018, increasing at a compound annual growth rate (CAGR) of 12.6% from 2013 through 2018. 

Report Includes

  • An overview of the global market for molecular diagnostics.
  • Analyses of global market trends, with data from 2010 through 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
  • Discussion of related issues, such as government regulation, reimbursement through insurance, patient confidentiality, and other legal ramifications.
  • Identification of scientific challenges and advances, including the latest trends.
  • Comprehensive company profiles and a patent analysis.

Report Scope

This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life sciences applications.  While the goal of all DNA-based diagnostic assays is similar, several different technologies can be employed.  BCC analyzes each technology in detail, determines major players and current market status, and presents forecasts of growth over the next five years.  Scientific challenges and advances including the latest trends are emphasized.  We examine government regulations, major collaborations, recent patents and factors affecting the industry worldwide.  In addition, we examine new directions for DNA diagnostic technologies and emerging applications in clinical diagnostics.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Analyst Credentials

JON EVANS has been involved in business development and research for the biotechnology industry since 1984. He has been involved in sales, market research and strategy analysis with Fortune 500 clients - with a particular focus on business development challenges and strategies to optimize market performance. He holds a B.S. degree in biology from Rutgers University and MBA in business analysis from San Francisco State University.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Molecular Diagnostics: Technologies and Global Markets180Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW5Free
Chapter- 4: REGULATIONS AND FINANCE27Free
Chapter- 5: COMMERCIAL MARKET TRENDS4Free
Chapter- 6: MARKET FOR MOLECULAR DIAGNOSTICS BY TECHNOLOGY24Free
Chapter- 7: MARKETS FOR MOLECULAR DIAGNOSTICS BY APPLICATION AND PRODUCTS21Free
Chapter- 8: PATENT ANALYSIS46Free
Chapter- 9: C. CRAMER & CO. GMBH48Free

Related Reports

Bioinformatics: Technologies and Global Markets

Published - Apr 2013 | Publisher - Dr. Cheryl Lee Barton | Code - BIO051B

The global bioinformatics market was valued at nearly $2.8 billion in 2011, nearly $3.2 billion in 2012, and is forecast to grow to nearly $7.5 billion by 2017 after increasing at a compound annual growth rate (CAGR) of 18.7%.

Drug Discovery Technologies

Published - Jun 2012 | Publisher - Marianna Tcherpakov | Code - BIO020D

The global market for drug discovery technologies and products reached $38.4 billion in 2011. It is expected to expand to $41.4 billion in 2012 and to $79.0 billion in 2017, a compound annual growth rate (CAGR) of 13.8% between 2012 and 2017.

DNA Sequencing: Emerging Technologies and Applications

Published - Mar 2012 | Publisher - John Bergin | Code - BIO045D

The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.

Antibody Drugs: Technologies and Global Markets

Published - Feb 2012 | Publisher - Esther Bosklopper | Code - BIO016H

The global market for therapeutic monoclonal antibodies (mAbs) was estimated at $44.6 billion in 2011.  With the rollout of at least eight new therapeutic mAb products and expanded indications for existing products expected during the forecast period, the global mAb market is expected to rise at a compound annual growth rate (CAGR) of 5.3% to nearly $58 billion in 2016.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 41

  • Summary Table: TOTAL GLOBAL MOLECULAR DIAGNOSTICS MARKET, THROUGH 2018
  • Table 1: MINIMUM INFORMATION ABOUT A MICROARRAY EXPERIMENT - MIAME 2.0
  • Table 2: MICROARRAY QUALITY CONTROL (MAQC) PROJECT
  • Table 3: U.S. LABORATORIES CLIA-CERTIFIED FOR MOLECULAR DIAGNOSTICS AND NUMBER OF DISEASE TESTS, 2012
  • Table 4: FDA-APPROVED IN VITRO COMPANION DIAGNOSTIC DEVICES AS OF DECEMBER 2012
  • Table 5: PGRN-RIKEN CGM COLLABORATIVE STUDIES UNDERWAY
  • Table 6: DIAGNOSTICS MANUFACTURER MERGERS AND ACQUISITIONS, 2004-2012
  • Table 7: GLOBAL MARKET FORECAST FOR DNA DIAGNOSTICS BY TECHNOLOGY, THROUGH 2018
  • Table 8: GLOBAL DNA DIAGNOSTICS MARKET BY PRODUCT SHARE, 2013
  • Table 9: GLOBAL MOLECULAR DIAGNOSTICS MANUFACTURERS BY MARKET SHARE, 2012
  • Table 10: GLOBAL MICROARRAY MARKET FORECAST FOR DNA DIAGNOSTICS BY TECHNOLOGY, THROUGH 2018
Sample Report

Recent Reports

Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO269A

The global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025 and is projected to reach $52.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.

Global DNA Forensics Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO266A

The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

Global Blood Platelet Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO268A

The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.

Digital Biomarkers: Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - BIO227B

The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030.

Whole Genome Sequencing: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO271A

The global market for whole genome sequencing is expected to grow from $3 billion in 2025 and forecast to reach $6.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2030.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - IAS006Q

The global market for sensors was valued at $195.1 billion in 2024 and is estimated to increase from $212.5 billion in 2025 to reach $323.3 billion by 2030, at a compound annual growth rate (CAGR) of 8.7% from 2025 through 2030.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Water and Wastewater Treatment Technologies: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - ENV008G

The global market for water and wastewater treatment technologies is expected to grow from $350.7 billion in 2025 and is projected to reach $591.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2025 to 2030.

Global Edge AI Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - IFT310A

The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Published - Jun-2008| Analyst - Amy Brock| Code - BIO063A

Report Highlights

This Report:

  • By the end of 2008, the global DNA diagnostics market is expected to be valued at $10.6 billion. The total market is projected to grow at a compound annual growth rate (CAGR) of 13.7% to reach $20.1 billion in 2013.
  • PCR-based diagnostic assays should claim the largest share of the market in 2008 and be worth $5.4 billion. The segment will reach $9.5 billion in 2013, for a CAGR of 11.9%.
  • The fastest growing segment of the DNA diagnostics market is the LOAC market, which is expected to reach $890 million in 2008 and $2.1 billion in 2013, for a CAGR of 18.7%.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Molecular Diagnostics: Technologies and Global Markets
Customize Report
AI: Your Say